OR WAIT null SECS
© 2023 MJH Life Sciences™ and Pharmaceutical Commerce. All rights reserved.
MarkMonitor sees 23% growth in offshore business exchanges for bulk pharmaceuticals and APIs
Although the entry of counterfeit products into legitimate pharmaceutical distribution appear to remain limited, there is noticeable growth in trade in bulk products and APIs, according to the latest Brandjacking Index, compiled by MarkMonitor (San Francisco). These products become available to consumers who patronize illicit online pharmacies, and based on some rules of thumb of e-commerce, MarkMonitor estimates that the volume of such sales has reached $11 billion, up form $4 billion in 2007, the first time MarkMonitor performed its study.
MarkMonitor tracks online activity in pharmaceutical e-commerce (and other branded products subject to counterfeiting) by using proprietary algorithms to uncover instances of “cybersquatting”—improper use of brandnames in Internet domains. By following six leading pharmaceutical brandnames, it found 20,000 instances of cybersquatting, including 652 exchanges—up 67% from 2007. By analyzing the volumes available for sale and public records of online traffic, it can derive estimates of the online sources and volume of such trade.
Other results from the study, conducted during the past summer:
“Scammers are opportunists, and by targeting the supply chain they’re positioning themselves to move the greatest amount of fake product they can,” said Frederick Felman, chief marketing officer at MarkMonitor. “This maximizes their return on the scam but it also poses a potential danger to peoples’ health and safety, not to mention brand reputation.” The company provides “enterprise brand protection” services to brand owners through its online monitoring services.